CEimpact Podcast
The CEimpact Podcast features two shows - GameChangers and Precept2Practice!
The GameChangers Clinical Conversations podcast, hosted by Josh Kinsey, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Pharmacist By Design™ subscribers can earn CE credit for each episode.
The Precept2Practice podcast, hosted by Kathy Schott, features information and resources for preceptors of students and residents. New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.
To support our shows, give us a follow and check back each week for our latest episodes.
- Update frequency
- every 6 days
- Average duration
- 28 minutes
- Episodes
- 352
- Years Active
- 2020 - 2025
New ASAM Guidelines for Ethanol Withdrawal | GameChangers
Ethanol use disorder continues to be a major problem in the U.S. The stress and anxiety related to the COVID-19 pandemic may exacerbate alcohol use disorder. Tune in to this episode to learn the lat…
00:23:00 |
Fri 07 Aug 2020
Rational Use of Skeletal Muscle Relaxants | GameChangers
Geoff Wall, PharmD delivers another great podcast. Pharmacists see skeletal muscle relaxant prescriptions daily but how much real experience do we have with these drugs? Do they work? Are they sa…
00:27:00 |
Fri 31 Jul 2020
Dexamethasone for Severe COVID Pneumonia: What Does the Data Show?
Overinflamation or cytokine storm is said to be the driver of acute respiratory disorder disease (ARDS) in COVID patients. A recent study conducted in the United Kingdom suggests that the steroid de…
00:27:00 |
Fri 24 Jul 2020
COVID Infections and the Latinx Patient: Perspectives from the Front Lines | GameChangers
The COVID-19 pandemic has disproportionally affected Latinx Americans. Learn how pharmacists can optimize patient care for Latinx patients by discussing how to overcome economic and language barrier…
00:26:20 |
Fri 17 Jul 2020
Cognitive Effects of Anticholinergics | GameChangers
Many patients over age 65 take daily medications that have anticholinergic properties. We know the addition of these drugs can affect quality of life and cognition. In this episode, we talk with Dr.…
00:24:00 |
Fri 10 Jul 2020
New 2020 ACR Guidelines for the Treatment of Gout | GameChangers
The American College of Rheumatology recently published new guidelines for the treatment of Gout. While gout is well understood and the medications to treat gout are both effective and affordable, im…
00:23:00 |
Fri 03 Jul 2020
Racism is a Public Health Emergency | GameChangers
Racism is a public health emergency and a root cause of social determinants of health. If we are to practice patient-centered care, and education our pharmacists to better serve their patients, we ou…
00:31:00 |
Fri 26 Jun 2020
Vitamin D: Repletion doses and the evidence of potential toxicity | GameChangers
Recently news suggests low vitamin D levels have been associated with increased risk of COVID-related morbidity and mortality. We know that vitamin D is a safe fat soluable vitamin that is difficult …
00:24:12 |
Fri 19 Jun 2020
Remdesivir for COVID-19: The NIAID Study Behind its Approval | GameChangers
Recently, Remdesivir was given Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) for use in COVID based on a heretofore unpublished study. The study, conducted b…
00:23:00 |
Fri 12 Jun 2020
Treating the other Epidemic: Buprenorphine for Opioid Use Disorder | GameChangers
Buprenorphine has been shown in numerous studies to be safe and effective in opioid use disorder, yet < 10% patients with Opioid Use Disorder receive drug treatment. In this episode, we discuss what …
00:21:30 |
Fri 05 Jun 2020
Evidence for SGLT2 Drugs for Heart Failure in Patients without Diabetes | GameChangers
Geoff Wall, PharmD & Jamie Pitlick, PharmD discussing SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood…
00:26:00 |
Fri 29 May 2020
Hypercoagulability with COVID-19 infection | GameChangers
GameChangers: In this episode, we describe the latest information concerning hypercoagulability with COVID-19 infection. In this episode, we describe the latest information concerning hypercoagulabi…
00:21:00 |
Fri 22 May 2020
Disclaimer: The podcast and artwork embedded on this page are the property of CEimpact. This content is not affiliated with or endorsed by eachpod.com.